GuidelineEye (London, England)2018
The Royal College of Ophthalmologists recommendations on screening for hydroxychloroquine and chloroquine users in the United Kingdom: executive summary.
Guideline in Eye (London, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04394416 (Randomized Double-Blind Placebo-Controlled Trial on the Safety and Efficacy of Imatinib for Hospitalized Adults With COVID-19), which is not on this map. Cited by 38 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Randomized Double-Blind Placebo-Controlled Trial on the Safety and Efficacy of Imatinib for Hospitalized Adults With COVID-19
Who cites it
38 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- [Is there a need for ophthalmological surveillance in the case of short-term hydroxychloroquine treatment during this COVID-19 pandemic?]Journal francais d'ophtalmologie · 2020Guideline
- Recommendations for eye care during the alarm state by the coronavirus disease pandemic COVID-19.Archivos de la Sociedad Espanola de Oftalmologia · 2020Guideline
- The Royal College of Ophthalmologists recommendations on screening for hydroxychloroquine and chloroquine users in the United Kingdom: executive summary.Eye (London, England) · 2018Guideline
- Chloroquine and hydroxychloroquine retinopathy in a cohort with rheumatic diseases in Mexico: prevalence, risk factors, and retinopathy patterns.Clinical rheumatology · 2026Article
- Progression of hydroxychloroquine-induced retinopathy after drug cessation.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026Observational
- 2025 Chinese guidelines for the diagnosis and treatment of systemic lupus erythematosus.Rheumatology and immunology research · 2025Article
- Refining lupus management: a comprehensive review of HCQ blood levels.Rheumatology advances in practice · 2025Review
- The incidence, monitoring coverage and clinical characteristics of hydroxychloroquine retinopathy in the United Kingdom.Eye (London, England) · 2024Observational
- Hydroxychloroquine monotherapy in sarcoidosis: Indications, efficacy, and side effects.Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG · 2024Article
- Factors associated with early hydroxychloroquine-induced retinal toxicity in patients with systemic lupus erythematosus.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2024Article
- Hydroxychloroquine in nephrology: current status and future directions.Journal of nephrology · 2023Review
- A nationwide survey of hydroxychloroquine retinopathy presenting to the hospital eye service in the United Kingdom.Eye (London, England) · 2023Article
- Review of Retinal Imaging Modalities for Hydroxychloroquine Retinopathy.Diagnostics (Basel, Switzerland) · 2023Review
- Outcomes of screening for hydroxychloroquine retinopathy at the Manchester Royal Eye Hospital: 2 years' audit.Eye (London, England) · 2023Article
- Systemic Lupus Erythematosus May Be a Risk Factor for Antimalarial-Induced Retinopathy Compared With Other Rheumatologic Diseases.ACR open rheumatology · 2023Article
- Hydroxychloroquine-induced Retinal Toxicity.Frontiers in pharmacology · 2023Review
- Retinal toxicity in a multinational inception cohort of patients with systemic lupus on hydroxychloroquine.Lupus science & medicine · 2022Article
- Attitudes and practices in the laboratory monitoring of conventional synthetic disease modifying anti-rheumatic drugs by rheumatologists and rheumatology trainees.BMC rheumatology · 2022Article
- Choriocapillaris Flow Deficits Quantification in Hydroxychloroquine Retinopathy Using Swept-Source Optical Coherence Tomography Angiography.Journal of personalized medicine · 2022Article
- MERCI: a machine learning approach to identifying hydroxychloroquine retinopathy using mfERG.Documenta ophthalmologica. Advances in ophthalmology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.